← All organizations

AnaptysBio, Inc.

For profitWebsite ↗

Also known as: AnaptysBio, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 4, 2023

Timeline

2000s

Jun 1, 2005
AnaptysBio, Inc.— Founded

Drugs by trial phase (4 distinct, 16 trials)

Phase 3 (1 own, 0 via acquisition)

anb019

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (31)

NCT06127043Lead sponsorPhase 2Dec 4, 2023
NCT06127043Study directorPhase 2Dec 4, 2023
NCT06041269Lead sponsorPhase 2Aug 31, 2023
NCT05935085Lead sponsorPhase 2Jun 13, 2023
NCT05935085Study directorPhase 2Jun 13, 2023
NCT05366855Lead sponsorPhase 3Apr 21, 2022
NCT05366855Study directorPhase 3Apr 21, 2022
NCT05352893Study directorPhase 3Apr 14, 2022
NCT05352893Lead sponsorPhase 3Apr 14, 2022
NCT05205070Lead sponsorPhase 2Dec 22, 2021
NCT05205070Study directorPhase 2Dec 22, 2021
NCT04856930Lead sponsorPhase 2May 31, 2021
NCT04856930Study directorPhase 2May 31, 2021
NCT04856917Lead sponsorPhase 2May 15, 2021
NCT04856917Study directorPhase 2May 15, 2021

Details

Founded: San Diego, CA, US Jun 1, 2005
Last known activity: Dec 4, 2023